000			01448 a2200433 4500
005			20250513160331.0
264		0	_c19990324
008			199903s 0 0 eng d
022			_a0304-3940
024	7		_a10.1016/s0304-3940(98)00814-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aSuo, Z
245	0	0	_aSoluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo. _h[electronic resource]
260			_bNeuroscience letters _cNov 1998
300			_a77-80 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAlzheimer Disease _xmetabolism
650	0	4	_aAmyloid beta-Peptides _xchemistry
650	0	4	_aAnimals
650	0	4	_aCerebral Cortex _xblood supply
650	0	4	_aCerebrovascular Circulation _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aPeptide Fragments _xchemistry
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSolubility
650	0	4	_aVascular Resistance _xdrug effects
650	0	4	_aVasoconstrictor Agents _xpharmacology
700	1		_aHumphrey, J
700	1		_aKundtz, A
700	1		_aSethi, F
700	1		_aPlaczek, A
700	1		_aCrawford, F
700	1		_aMullan, M
773	0		_tNeuroscience letters _gvol. 257 _gno. 2 _gp. 77-80
856	4	0	_uhttps://doi.org/10.1016/s0304-3940(98)00814-3 _zAvailable from publisher's website
999			_c9828694 _d9828694